Rhian Raftopoulos, Simon J Hickman, Ahmed Toosy, Basil Sharrack, Shahrukh Mallik, David Paling, Daniel R Altmann, Marios C Yiannakas, Prasad Malladi, Rose Sheridan, Ptolemaios G Sarrigiannis, Nigel Hoggard, Martin Koltzenburg, Claudia A M Gandini Wheeler-Kingshott, Klaus Schmierer, Gavin Giovannoni, David H Miller, Raju Kapoor
BACKGROUND: Acute demyelinating optic neuritis, a common feature of multiple sclerosis, can damage vision through neurodegeneration in the optic nerve and in its fibres in the retina. Inhibition of voltage-gated sodium channels is neuroprotective in preclinical models. In this study we aimed to establish whether sodium-channel inhibition with phenytoin is neuroprotective in patient with acute optic neuritis. METHODS: We did a randomised, placebo-controlled, double-blind phase 2 trial at two UK academic hospitals in London and Sheffield...
March 2016: Lancet Neurology